European Equities Traded in the US as American Depositary Receipts Trend Slightly in Thursday Trading

MT Newswires Live07-25

European equities traded in the US as American depositary receipts were moving marginally higher late Thursday morning, rising 0.15% to 1,411.92 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by consumer goods company Unilever (UL) and biopharmaceutical company argenx (ARGX), which rose 6.3% and 3.4% respectively. They were followed by telecommunications company Nokia (NOK) and pharmaceutical company Sanofi (SNY), which increased 4.1% and 3.7% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion Biotech (EVAX), which fell 4.7% and 3.3% respectively. They were followed by financial services company Banco Santander (SAN) and pharmaceutical company Novo Nordisk (NVO), which were down 3.1% and 2.6% respectively.

From the UK and Ireland, the gainers were led by tobacco company British American Tobacco (BTI) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which were up 4.7% and 3.7% respectively. They were followed by biopharmaceutical company Verona Pharma (VRNA) and telecommunications operator Vodafone Group (VOD), which rose 3.1% and 2.3% respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and pharmaceutical company AstraZeneca (AZN), which dropped 3.9% and 3% respectively. They were followed by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which were off 2.9% and 2.4% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment